Juan J. Cruz-Hernandez - Publications

ctDNA-derived copy-number signatures associated with immune checkpoint inhibitor resistance beyond PD-L1 and TMB in advanced NSCLC.

Journal: Frontiers in oncology

Published: May 08, 2026

Effects of a resistance training program on chemotherapy-induced peripheral neuropathy, cancer-related fatigue, muscle strength and physical activity in colorectal cancer patients undergoing chemotherapy: a pilot randomized controlled trial.

Journal: Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico

Published: March 18, 2026

Spanish adaptation and validation of Mishel's Uncertainty in Illness Scale (MUIS-A) in cancer patients.

Journal: BMC psychology

Published: February 19, 2026

Exploratory plasma ctDNA genomic biomarkers identified by whole-exome sequencing and a novel bioinformatics pipeline in advanced driver-negative NSCLC.

Journal: Scientific reports

Published: January 17, 2026

Cross-Species and Tissue-Agnostic Prediction of Human Cancer Treatment Response using AI-Powered Cellular Morphometric Biomarkers from a Genetically Diverse Erbb2 Mouse Model.

Journal: medRxiv : the preprint server for health sciences

Published: September 26, 2025

A Home-Based Interdisciplinary Intervention to Enhance Functionality in Oncology Patients: Results from a Clinical Trial.

Journal: Journal of clinical medicine

Published: May 26, 2025

Impact of a multimodal effort re-education programme on functionality, physical performance, and functional capacity in cancer patients with dyspnoea: a randomised experimental study.

Journal: Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer

Published: March 21, 2024

Impact of functional re-education and environmental adaptation in cancer patients with respiratory pathology: Study protocol.

Journal: PloS one

Published: November 08, 2023

NCAPH Drives Breast Cancer Progression and Identifies a Gene Signature that Predicts Luminal A Tumor Recurrence.

Journal: Research square

Published: October 27, 2023

NCAPH drives breast cancer progression and identifies a gene signature that predicts luminal a tumour recurrence.

Journal: Clinical and translational medicine

Published: October 21, 2023

Efficacy and safety of PARP inhibitor in non-small cell lung cancer: a systematic review with meta-analysis.

Journal: Chinese clinical oncology

Published: June 25, 2023

Intermediate Molecular Phenotypes to Identify Genetic Markers of Anthracycline-Induced Cardiotoxicity Risk.

Journal: Cells

Published: April 17, 2023